持续性掌疹与Teprotumumab治疗相关。

IF 1.2 4区医学 Q3 OPHTHALMOLOGY

Ophthalmic Plastic and Reconstructive Surgery Pub Date : 2025-06-09 DOI:10.1097/IOP.0000000000002985

Lance R He, George A Villatoro, Michael T Yen

{"title":"持续性掌疹与Teprotumumab治疗相关。","authors":"Lance R He, George A Villatoro, Michael T Yen","doi":"10.1097/IOP.0000000000002985","DOIUrl":null,"url":null,"abstract":"A 77-year-old male developed bilateral palmar rashes during treatment of active thyroid eye disease with teprotumumab that persisted even after completing treatment. This pattern of palmar rash and its persistence following completion of the treatment course has not been previously reported. The presentation highlights the importance of monitoring adverse effects during treatment with teprotumumab, as some may persist beyond treatment.","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":" ","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Persistent Palmar Rash Associated with Teprotumumab Treatment.\",\"authors\":\"Lance R He, George A Villatoro, Michael T Yen\",\"doi\":\"10.1097/IOP.0000000000002985\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A 77-year-old male developed bilateral palmar rashes during treatment of active thyroid eye disease with teprotumumab that persisted even after completing treatment. This pattern of palmar rash and its persistence following completion of the treatment course has not been previously reported. The presentation highlights the importance of monitoring adverse effects during treatment with teprotumumab, as some may persist beyond treatment.\",\"PeriodicalId\":19588,\"journal\":{\"name\":\"Ophthalmic Plastic and Reconstructive Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmic Plastic and Reconstructive Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/IOP.0000000000002985\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic Plastic and Reconstructive Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IOP.0000000000002985","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

一名77岁男性患者在使用teprotumumab治疗活动性甲状腺眼病期间出现双侧掌疹，即使在完成治疗后仍持续存在。这种手掌皮疹的模式及其在疗程结束后的持续性，以前没有报道过。该报告强调了在teprotumumab治疗期间监测不良反应的重要性，因为有些不良反应可能在治疗后持续存在。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Persistent Palmar Rash Associated with Teprotumumab Treatment.

A 77-year-old male developed bilateral palmar rashes during treatment of active thyroid eye disease with teprotumumab that persisted even after completing treatment. This pattern of palmar rash and its persistence following completion of the treatment course has not been previously reported. The presentation highlights the importance of monitoring adverse effects during treatment with teprotumumab, as some may persist beyond treatment.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Ophthalmic Plastic and Reconstructive Surgery 医学-外科

CiteScore

2.50

自引率

10.00%

发文量

322

审稿时长

3-8 weeks

期刊介绍： Ophthalmic Plastic and Reconstructive Surgery features original articles and reviews on topics such as ptosis, eyelid reconstruction, orbital diagnosis and surgery, lacrimal problems, and eyelid malposition. Update reports on diagnostic techniques, surgical equipment and instrumentation, and medical therapies are included, as well as detailed analyses of recent research findings and their clinical applications.